Table 1 Patient and tumor characteristics
From: FDG-PET/CT in predicting aggressiveness of rectal cancer
Characteristic | Number [%] |
|---|---|
Age median, range | 60 [32–86] |
Sex | |
Male | 19 [57.57%] |
Female | 14 [42.42 %] |
Location | |
Upper rectum | 19 [57.6%] |
Middle rectum | 3 [9.1%] |
Lower rectum | 7 [21.2%] |
Mid and lower rectum | 4 [12.1] |
Histopathology | |
Moderately differentiated | 19 [57.6%] |
Poorly differentiated | 10 [30.3%] |
Mucinous adenocarcinoma | 4 [12.1%] |
Clinical stage | |
II | 10 [30.3%] |
IIIA | 6 [18.2%] |
IV | 17 [51.5%] |
T stage | |
T3 | 32 [96.96 %] |
T4 | 1 [3.03%] |
N stage | |
N0 | 13 [39.3%] |
N1 | 12 [36.36%] |
N2 | 8 [24.24%] |
FDG-PET/CT results, median, range | |
SUVmax | 17.9 [5.3–53.82] |
SUV mean | 10.46 [2.7–40.5] |
MTV | 21.5 [3.9–62.5] |
TLG | 234.442 [36.9–2521.1] |